![Stephen Hahn](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Stephen Hahn
Chief Tech/Sci/R&D Officer at
TURN THERAPEUTICS INC.
Profile
Stephen M Hahn is currently the Chief Executive Officer at Nucleus Radiopharma, Inc. since 2025.
He is also a Director at Ion Beam Applications SA and Faeth Therapeutics, Inc., both positions starting in 2026.
Additionally, Mr. Hahn holds the position of Head-Executive Clinical & Regulatory at Turn Therapeutics, Inc. Mr. Hahn completed undergraduate education at William Marsh Rice University and graduate education at Temple University (Pennsylvania).
Stephen Hahn active positions
| Companies | Position | Start |
|---|---|---|
| ION BEAM APPLICATIONS, SA | Director/Board Member | 2026-06-15 |
| FAETH THERAPEUTICS, INC. | Director/Board Member | 2026-06-11 |
| TURN THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | - |
Nucleus Radiopharma, Inc.
 Nucleus Radiopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a end-to-end contract development and manufacturing organization | Chief Executive Officer | 2025-08-19 |
Training of Stephen Hahn
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
47
1st degree connections
6
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Ion Beam Applications SA
 Ion Beam Applications SA Medical SpecialtiesHealth Technology Supplies medical, dental and hospital equipment | Health Technology |
Rice University
 Rice University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Temple University (Pennsylvania)
 Temple University (Pennsylvania) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sensei Biotherapeutics, Inc.
 Sensei Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company, which develops immunotherapies for cancers and infectious disease | Health Technology |
Global Health Solutions Inc
 Global Health Solutions Inc Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical and medical device development company that provides solutions for dermatological diseases | Health Technology |
Nucleus Radiopharma, Inc.
Nucleus Radiopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a end-to-end contract development and manufacturing organization | Health Technology |
- Stock Market
- Insiders
- Stephen Hahn
